Company intelligence / Profile preview

BIORCHESTRA

Daejeon, South Koreax.com ↗

Ownership: Private
Employees: ~20
Development stage: Preclinical

Overview

BIORCHESTRA develops proprietary RNA-based therapeutics targeting neurodegenerative and rare CNS diseases. Its lead program aims at Alzheimer’s disease by modulating specific microRNAs upstream of pathological proteins like Aβ and tau. The company has demonstrated preclinical efficacy with its antisense oligonucleotide approach delivered via a novel intravenous system capable of crossing the blood-brain barrier. Clinical entry was anticipated for their Alzheimer’s candidate in early/mid–2024.

Therapeutic areas: Rare DiseasesNeurology
Modalities: RNA-based therapeutics (including antisense oligonucleotides, siRNA, microRNA modulators)
Industry: Biotech

Drug pipeline

4 assets

BMD-001

Preclinical

3 more assets in the full pipeline.

Request access →

Partnerships

Dayli PartnersCKD Venture CapitalLSK Investmentopen innovation collaborations with global pharmaceutical companies on drug delivery systems.

Beyond the preview

Go deeper on BIORCHESTRA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BIORCHESTRA.

Explore the full profile